Skip to main content
About us
Overview
Senior Management
Board of Directors
Investors
Platform
Background
Hybrid interferons
Our pipeline
Alfacyte™
Dermacyte™
News and events
Press releases
Contact
Investors
To find out more about investment opportunities with us,
please get in touch
.
Peter Bains
E:
[email protected]
Richard Morgan
E:
[email protected]
Walbrook PR Ltd
T:
+ 44 (0)20 7933 8780
E:
[email protected]